StockData
Revelation Biosciences, Inc. logo

Revelation Biosciences, Inc. (REVB) stock

REVBNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVBW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.88+0.06 (+1.57%)

Close on Nov 17, 2026Market cap $15.46MP/E –Yield –

Revelation Biosciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Revelation Biosciences's market cap was $17.04M on Nov 11, 2026, against $95.85M a year earlier. Over the last 5 years it ranged from $1.79M to $102.72B, with a median of $3.37B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$17.04M-78.8%
2025Dec 31, 2025$80.30M-97.0%
2024Dec 31, 2024$2.66B-84.3%
2023Dec 29, 2023$16.95B-31.5%
2022Dec 30, 2022$24.76B-75.9%
2021Dec 31, 2021$102.72B-14.4%
2020Dec 31, 2020$119.94B–

More Revelation Biosciences figures

See a number that looks wrong?